0001562180-20-006487.txt : 20201102
0001562180-20-006487.hdr.sgml : 20201102
20201102151154
ACCESSION NUMBER: 0001562180-20-006487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201029
FILED AS OF DATE: 20201102
DATE AS OF CHANGE: 20201102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seth Alpna
CENTRAL INDEX KEY: 0001721020
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 201280175
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-10-29
false
0000842023
BIO-TECHNE Corp
TECH
0001721020
Seth Alpna
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
true
false
false
false
Common Stock
2020-10-29
4
A
false
391.00
0.00
A
2139.00
D
Stock Option (Right to Buy)
255.69
2020-10-29
4
A
false
1507.00
0.00
A
2030-10-29
Common Stock
1507.00
1507.00
D
Stock Option (Right to Buy)
201.64
2020-10-24
2029-10-24
Common Stock
2011.00
2011.00
D
Stock Options (Right to Buy)
179.84
2019-10-24
2028-10-25
Common Stock
1898.00
1898.00
D
Stock Options (Right to Buy)
125.05
2018-10-25
2027-10-26
Common Stock
3125.00
3125.00
D
The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne 2021 annual meeting of shareholders.
/s/ Brenda S. Furlow, attorney in fact for Seth Alpna pursuant to Power of Attorney previously filed
2020-11-02
EX-24
2
sethpoa2017.txt
SETHPOA2017
POWER OF ATTORNEY
The undersigned hereby constitutes and
appoints Brenda S. Furlow, James Hippel, Anna
Weispfenning, Melodie R. Rose, Andrew Nick,
Sarah Tucher or either of them acting alone,
the undersigned's true and lawful attorneys-
in-fact and agent with full power of
substitution and resubstitution, for the
undersigned and in the undersigned's name,
place and stead, in any and all capacities,
to sign any or all Forms 3, Forms 4 and
Forms 5 relating to beneficial ownership of
securities of Bio-Techne Corporation (the
"Issuer"), to file the same, with all
exhibits thereto and other documents in
connection therewith, with the Securities and
Exchange Commission and to deliver a copy of
the same to the Issuer, granting unto said
attorney-in-fact and agent full power and
authority to do and perform each and every
act and thing requisite and necessary to be
done in and about the premises, as fully to
all intents and purposes as the undersigned
might or could do in person, hereby ratifying
and confirming all said attorneys-in-fact and
agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue
thereof. The undersigned acknowledges that
the foregoing attorney-in-fact, in serving in
such capacity at the request of the
undersigned, is not assuming any of the
undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of
1934.
This Power of Attorney shall remain in
effect until such time as the undersigned is
no longer subject to the provisions of
Section 16 of the Securities Exchange Act of
1934 with respect to securities of the
Issuer.
IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be executed
as of this 26th day of October, 2017.
/s/ Alpna Seth